Clinical Trials
3 trialsNCT04948333 2026-03-18
Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
Novartis
Phase 3 Completed
NCT02627677 2021-11-26
OPTIC-2L
Takeda
Phase 3 Terminated
NCT04015024 2019-07-16
A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown